Literature DB >> 21717520

Interleukin-23 receptor polymorphism as a risk factor for oral cancer susceptibility.

Ming-Hsien Chien1, Chung-Han Hsin, Lin Shih-Shen Chou, Tsung-Te Chung, Chien-Huang Lin, Meng-Shih Weng, Ming-Yung Chou, Mu-Kuan Chen, Shun-Fa Yang.   

Abstract

BACKGROUND: The purpose of this study was to evaluate the influence of genetic polymorphisms of interleukin (IL)-23 and the IL-23 receptor (IL-23R) on the susceptibility to oral cancer.
METHODS: Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to measure polymorphisms of these genes in 240 controls and 240 patients with oral cancer.
RESULTS: Individuals with at least 1 varied C allele of rs10889677 (IL-23R polymorphism) had a 1.553-fold risk (95% confidence interval [CI], 1.073-2.241) of developing oral cancer compared with patients with the wild-type A/A homozygote. Patients with oral cancer with at least 1 varied C allele of rs10889677 had a 1.931-fold risk of tumor lymph node metastasis compared with patients with the C/C homozygote.
CONCLUSION: The varied C allele of the IL-23R gene may be considered a factor contributing to increased susceptibility and may be a predictive factor for tumor lymph node metastasis in Taiwanese with oral cancer.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21717520     DOI: 10.1002/hed.21779

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  10 in total

1.  Association of interleukin-23 receptor gene polymorphisms with risk of bladder cancer in Chinese.

Authors:  Tielong Tang; Hui Xue; Shu Cui; Zhiyong Gong; Zhonghai Fei; Shulin Cheng; Chunyan Gui
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

2.  Inferring novel genes related to oral cancer with a network embedding method and one-class learning algorithms.

Authors:  Lei Chen; Yu-Hang Zhang; Guohua Huang; Xiaoyong Pan; Tao Huang; Yu-Dong Cai
Journal:  Gene Ther       Date:  2019-08-27       Impact factor: 5.250

Review 3.  Genotypic distribution of single nucleotide polymorphisms in oral cancer: global scene.

Authors:  Shaleen Multani; Dhananjaya Saranath
Journal:  Tumour Biol       Date:  2016-09-20

4.  A miRNA binding site single-nucleotide polymorphism in the 3'-UTR region of the IL23R gene is associated with breast cancer.

Authors:  Lihong Wang; Wei Liu; Wei Jiang; Jing Lin; Yongdong Jiang; Bo Li; Da Pang
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

5.  IL-23R is Epigenetically Regulated and Modulated by Chemotherapy in Non-Small Cell Lung Cancer.

Authors:  Anne-Marie Baird; Eilis Dockry; Anne Daly; Emma Stack; Derek G Doherty; Kenneth J O'Byrne; Steven G Gray
Journal:  Front Oncol       Date:  2013-06-19       Impact factor: 6.244

6.  Polymorphisms of genes encoding cytokines predict the risk of high-grade bladder cancer and outcomes of BCG immunotherapy.

Authors:  Wojciech Krajewski; Lidia Karabon; Anna Partyka; Anna Tomkiewicz; Sławomir Poletajew; Andrzej Tukiendorf; Anna Kołodziej; Romuald Zdrojowy
Journal:  Cent Eur J Immunol       Date:  2020       Impact factor: 2.085

Review 7.  Tumor microenvironment and immunotherapy of oral cancer.

Authors:  Chang Liu; Min Wang; Haiyang Zhang; Chunyan Li; Tianshou Zhang; Hong Liu; Song Zhu; Jie Chen
Journal:  Eur J Med Res       Date:  2022-10-08       Impact factor: 4.981

8.  Functional polymorphisms in interleukin-23 receptor and susceptibility to esophageal squamous cell carcinoma in Chinese population.

Authors:  Bin Ni; Shaomu Chen; Hongya Xie; Haitao Ma
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

9.  Functional IL-23R rs10889677 genetic polymorphism and risk of multiple solid tumors: a meta-analysis.

Authors:  Shanliang Zhou; Yueqin Ruan; Hongchen Yu; Yunzhi Chen; Yongjun Yao; Yanhui Ma; Yan Gao
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

Review 10.  Association of IL-23R Polymorphisms (rs6682925, rs10889677, rs1884444) With Cancer Risk: A PRISMA-Compliant Meta-Analysis.

Authors:  Xing-Han Liu; Zhi-Ming Dai; Hua-Feng Kang; Shuai Lin; Xiao-Bin Ma; Meng Wang; Kang Liu; Cong Dai; Xi-Jing Wang; Zhi-Jun Dai
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.